These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 37108784)

  • 1. APC Loss Prevents Doxorubicin-Induced Cell Death by Increasing Drug Efflux and a Chemoresistant Cell Population in Breast Cancer.
    Stefanski CD; Arnason A; Maloney S; Kotsen J; Powers E; Zhang JT; Prosperi JR
    Int J Mol Sci; 2023 Apr; 24(8):. PubMed ID: 37108784
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NFκBP65 transcription factor modulates resistance to doxorubicin through ABC transporters in breast cancer.
    Velaei K; Samadi N; Soltani S; Barazvan B; Soleimani Rad J
    Breast Cancer; 2017 Jul; 24(4):552-561. PubMed ID: 27878697
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multidrug resistance mediated by ABC transporters in osteosarcoma cell lines: mRNA analysis and functional radiotracer studies.
    Gomes CM; van Paassen H; Romeo S; Welling MM; Feitsma RI; Abrunhosa AJ; Botelho MF; Hogendoorn PC; Pauwels E; Cleton-Jansen AM
    Nucl Med Biol; 2006 Oct; 33(7):831-40. PubMed ID: 17045162
    [TBL] [Abstract][Full Text] [Related]  

  • 4. APC selectively mediates response to chemotherapeutic agents in breast cancer.
    VanKlompenberg MK; Bedalov CO; Soto KF; Prosperi JR
    BMC Cancer; 2015 Jun; 15():457. PubMed ID: 26049416
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of β-elemene on the kinetics of intracellular transport of d-luciferin potassium salt (ABC substrate) in doxorubicin-resistant breast cancer cells and the associated molecular mechanism.
    Tang CY; Zhu LX; Yu JD; Chen Z; Gu MC; Mu CF; Liu Q; Xiong Y
    Eur J Pharm Sci; 2018 Jul; 120():20-29. PubMed ID: 29704644
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of ABC-cassette transporters (MDR1, MRP1, BCRP) in the development of primary and acquired multiple drug resistance in patients with early and metastatic breast cancer.
    Kovalev AA; Tsvetaeva DA; Grudinskaja TV
    Exp Oncol; 2013 Dec; 35(4):287-90. PubMed ID: 24382439
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Resveratrol enhances chemosensitivity of doxorubicin in multidrug-resistant human breast cancer cells via increased cellular influx of doxorubicin.
    Kim TH; Shin YJ; Won AJ; Lee BM; Choi WS; Jung JH; Chung HY; Kim HS
    Biochim Biophys Acta; 2014 Jan; 1840(1):615-25. PubMed ID: 24161697
    [TBL] [Abstract][Full Text] [Related]  

  • 8. APC loss in breast cancer leads to doxorubicin resistance via STAT3 activation.
    VanKlompenberg MK; Leyden E; Arnason AH; Zhang JT; Stefanski CD; Prosperi JR
    Oncotarget; 2017 Nov; 8(61):102868-102879. PubMed ID: 29262529
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cell density modulates chemoresistance in breast cancer cells through differential expression of ABC transporters.
    Shivhare S; Das A
    Mol Biol Rep; 2023 Jan; 50(1):215-225. PubMed ID: 36319789
    [TBL] [Abstract][Full Text] [Related]  

  • 10. siRNAs targeting multidrug transporter genes sensitise breast tumour to doxorubicin in a syngeneic mouse model.
    Tiash S; Chowdhury EH
    J Drug Target; 2019 Mar; 27(3):325-337. PubMed ID: 30221549
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of BCRP/MXR, MRP1 and MDR1/P-Glycoprotein on thermoresistant variants of atypical and classical multidrug resistant cancer cells.
    Stein U; Lage H; Jordan A; Walther W; Bates SE; Litman T; Hohenberger P; Dietel M
    Int J Cancer; 2002 Feb; 97(6):751-60. PubMed ID: 11857350
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combination of 7-
    Chen Y; Li X; Shi L; Ma P; Wang W; Wu N; Gan Y; Han X; Huang S; Kang X; Liu S; Zhen Y
    Aging (Albany NY); 2022 Sep; 14(17):7156-7169. PubMed ID: 36107024
    [TBL] [Abstract][Full Text] [Related]  

  • 13. APC loss affects DNA damage repair causing doxorubicin resistance in breast cancer cells.
    Stefanski CD; Keffler K; McClintock S; Milac L; Prosperi JR
    Neoplasia; 2019 Dec; 21(12):1143-1150. PubMed ID: 31759252
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vielanin P enhances the cytotoxicity of doxorubicin via the inhibition of PI3K/Nrf2-stimulated MRP1 expression in MCF-7 and K562 DOX-resistant cell lines.
    Gao HL; Xia YZ; Zhang YL; Yang L; Kong LY
    Phytomedicine; 2019 May; 58():152885. PubMed ID: 31009836
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Icariin enhances cytotoxicity of doxorubicin in human multidrug-resistant osteosarcoma cells by inhibition of ABCB1 and down-regulation of the PI3K/Akt pathway.
    Wang Z; Yang L; Xia Y; Guo C; Kong L
    Biol Pharm Bull; 2015; 38(2):277-84. PubMed ID: 25747987
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of MDR modulators verapamil and promethazine on gene expression levels of MDR1 and MRP1 in doxorubicin-resistant MCF-7 cells.
    Dönmez Y; Akhmetova L; İşeri ÖD; Kars MD; Gündüz U
    Cancer Chemother Pharmacol; 2011 Apr; 67(4):823-8. PubMed ID: 20563580
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Forced expression of heat shock protein 27 (Hsp27) reverses P-glycoprotein (ABCB1)-mediated drug efflux and MDR1 gene expression in Adriamycin-resistant human breast cancer cells.
    Kanagasabai R; Krishnamurthy K; Druhan LJ; Ilangovan G
    J Biol Chem; 2011 Sep; 286(38):33289-300. PubMed ID: 21784846
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ATP-dependent activity and mitochondrial localization of drug efflux pumps in doxorubicin-resistant breast cancer cells.
    Dartier J; Lemaitre E; Chourpa I; Goupille C; Servais S; Chevalier S; Mahéo K; Dumas JF
    Biochim Biophys Acta Gen Subj; 2017 May; 1861(5 Pt A):1075-1084. PubMed ID: 28214549
    [TBL] [Abstract][Full Text] [Related]  

  • 19. miR-145 sensitizes breast cancer to doxorubicin by targeting multidrug resistance-associated protein-1.
    Gao M; Miao L; Liu M; Li C; Yu C; Yan H; Yin Y; Wang Y; Qi X; Ren J
    Oncotarget; 2016 Sep; 7(37):59714-59726. PubMed ID: 27487127
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increasing the cytotoxicity of doxorubicin in breast cancer MCF-7 cells with multidrug resistance using a mesoporous silica nanoparticle drug delivery system.
    Wang X; Teng Z; Wang H; Wang C; Liu Y; Tang Y; Wu J; Sun J; Wang H; Wang J; Lu G
    Int J Clin Exp Pathol; 2014; 7(4):1337-47. PubMed ID: 24817930
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.